![](/img/cover-not-exists.png)
Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
Kotaka, Masahito, Yamanaka, Takeharu, Yoshino, Takayuki, Manaka, Dai, Eto, Tetsuya, Hasegawa, Junichi, Takagane, Akinori, Nakamura, Masato, Kato, Takeshi, Munemoto, Yoshinori, Nakamura, Fumitaka, BandVolume:
3
Language:
english
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2018-000354
Date:
April, 2018
File:
PDF, 534 KB
english, 2018